Therapeutic Drug Monitoring · 2006 · 31 citations · 8 references
PharmacyPharmacologyToxicologyInfant HealthNeonatologyPsychopharmacologyNeonatal PharmacologyPerinatal PharmacologyPerinatal ToxicologyPlacental ToxicologyPrenatal ToxicityPrenatal ToxicologyClinical SymptomsDrug Safety In NewbornsPerinatal Drug ExposurePerinatal Drug ToxicityPerinatal ToxicityPharmaceutical Exposure During PregnancyPrenatal Drug ExposureSerotonin Toxicity
There are several case reports and case series that have examined the acute effects of selective serotonin reuptake inhibitors (SSRIs) on the newborn. There is considerable controversy whether the reported symptoms represent withdrawal from the SSRI or toxicity caused by the SSRI. A case of an infant who was exposed to paroxetine during pregnancy is presented. This case supports the notion of serotonin toxicity and is believed to be the first report that substantiates clinical symptoms with serum levels of the offending SSRI.
8
Kari Laine, Ulla Ekblad, Pentti Kero · Archives of General Psychiatry · 2003 · 335 citations · Full text
Medicine, Obstetrics, Pharmacology +17
Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
Hedvig Nordeng, Rolf Lindemann, KV Perminov et al. · Acta Paediatrica · 2001 · 159 citations
Medicine, Pharmacology, Psychiatry +17